|
TT-00420 (tinengotinib) Clinical Trials
1 actively recruiting trial
Pipeline
Phase 2: 1
Top Sponsors
- Akeso1
Indications
- Liver Disease1
- Hepatocellular Carcinoma (HCC)1
- Liver Cancer1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.